Cancer Research AACR Conference on Molecular Diagnostics - 2008  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 3294-3299, August 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akama, T. O.
Right arrow Articles by Hayashizaki, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akama, T. O.
Right arrow Articles by Hayashizaki, Y.

Restriction Landmark Genomic Scanning (RLGS-M)-based Genome-wide Scanning of Mouse Liver Tumors for Alterations in DNA Methylation Status1

Tomoya O. Akama, Yasushi Okazaki, Mitsuteru Ito, Hisato Okuizumi, Hideaki Konno, Masami Muramatsu, Christoph Plass, William A. Held and Yoshihide Hayashizaki2

Genome Science Laboratory, The Physical and Chemical Research (RIKEN), 3-1-1 Koyadai, Tsukuba, Ibaraki 305 Japan [T. O. A., Y. O., M. I., H. O., H. K., M. M., Y. H.] and Department of Molecular and Cellular Biology, Roswell Park Cancer Institute, Buffalo, New York 14263 [C. P., W. A. H.]

Restriction landmark genomic scanning for methylation (RLGS-M) was used to detect, and subsequently clone, genomic regions with alterations in DNA methylation associated with tumorigenesis. Use of a methylation-sensitive enzyme for the landmark cleavage allows analysis of changes in methylation patterns. In this study, we used RLGS-M to analyze SV40 T antigen-induced mouse liver tumors derived from interspecific F1 hybrids between Mus spretus (S) and C57BL/6 (B6). Because 575 S- and B6-specific RLGS loci/spots have been mapped, tumor-related alterations in the RLGS profile could be immediately localized to specific chromosomal regions. We previously found that the loss of contiguous loci/spots could be attributed primarily to DNA loss, whereas loss of solitary loci/spots could be attributed primarily to DNA methylation. In this study, we examined 30 mouse liver tumor samples for loss of the 507 mapped loci/spots. Fourteen solitary loci/spots found to be absent or reduced in more than 75% of tumor samples were cloned and subjected to DNA sequence analyses. Two loci were identified as {alpha}4 integrin and p16/CDKN2, genes reported to be involved in tumorigenesis. Thus, RLGS-M can detect alterations in the methylation status of known tumor suppressor genes and provide a method for detecting and subsequently cloning novel genomic regions that undergo alterations in methylation during tumorigenesis.

1 This study was supported by special coordination funds and a research grant for the Genome Exploration Research Project from the Science and Technology Agency of the Japanese government; a grant-in-aid for scientific research on priority areas and the Human Genome Program from the Ministry of Education, Science, Sports and Culture, Japan; a grant for research on aging and health; a grant-in-aid for a second term comprehensive 10-year strategy for cancer control from the Ministry of Health and Welfare of the Japanese government (to Y. H.); and a grant from Core Research of Evolution Science and Technology (CREST) from Japan Science and Technology Corporation (JST). This work was also supported by Grant RO1-CA686612 from the National Cancer Institute (to W. A. H.).

2 To whom requests for reprints should be addressed.

Received 3/ 4/97. Accepted 6/ 2/97.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
R. M. Brena and J. F. Costello
Genome-epigenome interactions in cancer
Hum. Mol. Genet., April 15, 2007; 16(R1): R96 - R105.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
M. Bibikova, Z. Lin, L. Zhou, E. Chudin, E. W. Garcia, B. Wu, D. Doucet, N. J. Thomas, Y. Wang, E. Vollmer, et al.
High-throughput DNA methylation profiling using universal bead arrays
Genome Res., March 1, 2006; 16(3): 383 - 393.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Hong, A. Maunakea, P. Jun, A. W. Bollen, J. G. Hodgson, D. D. Goldenberg, W. A. Weiss, and J. F. Costello
Shared Epigenetic Mechanisms in Human and Mouse Gliomas Inactivate Expression of the Growth Suppressor SLC5A8
Cancer Res., May 1, 2005; 65(9): 3617 - 3623.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
T. Matsuyama, M. T. Kimura, K. Koike, T. Abe, T. Nakano, T. Asami, T. Ebisuzaki, W. A. Held, S. Yoshida, and H. Nagase
Global methylation screening in the Arabidopsis thaliana and Mus musculus genome: applications of virtual image restriction landmark genomic scanning (Vi-RLGS)
Nucleic Acids Res., August 1, 2003; 31(15): 4490 - 4496.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. Wu, L. Lin, D. G. Beer, L. H. Ellenson, B. J. Lamb, J.-M. Rouillard, R. Kuick, S. Hanash, D. R. Schwartz, E. R. Fearon, et al.
Amplification and Overexpression of the L-MYC Proto-Oncogene in Ovarian Carcinomas
Am. J. Pathol., May 1, 2003; 162(5): 1603 - 1610.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
S. E. COTTRELL and P. W. LAIRD
Sensitive Detection of DNA Methylation
Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 120 - 130.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Majumder, K. Ghoshal, J. Datta, S. Bai, X. Dong, N. Quan, C. Plass, and S. T. Jacob
Role of de Novo DNA Methyltransferases and Methyl CpG-binding Proteins in Gene Silencing in a Rat Hepatoma
J. Biol. Chem., May 3, 2002; 277(18): 16048 - 16058.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. J. Rush, Z. Dai, D. J. Smiraglia, X. Gao, F. A. Wright, M. Fruhwald, J. F. Costello, W. A. Held, L. Yu, R. Krahe, et al.
Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci
Blood, May 15, 2001; 97(10): 3226 - 3233.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
J. F Costello and C. Plass
Methylation matters
J. Med. Genet., May 1, 2001; 38(5): 285 - 303.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. Tateno, Y. Fukunishi, S. Komatsu, Y. Okazaki, J. Kawai, K. Shibata, M. Itoh, M. Muramatsu, W. A. Held, and Y. Hayashizaki
Identification of a Novel Member of the Snail/Gfi-1 Repressor Family, mlt 1, Which Is Methylated and Silenced in Liver Tumors of SV40 T Antigen Transgenic Mice
Cancer Res., February 1, 2001; 61(3): 1144 - 1153.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. Toyota, C. Ho, M. Ohe-Toyota, S. B. Baylin, and J.-P. J. Issa
Inactivation of CACNA1G, a T-Type Calcium Channel Gene, by Aberrant Methylation of Its 5' CpG Island in Human Tumors
Cancer Res., September 1, 1999; 59(18): 4535 - 4541.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Toyota, C. Ho, N. Ahuja, K.-W. Jair, Q. Li, M. Ohe-Toyota, S. B. Baylin, and J.-P. J. Issa
Identification of Differentially Methylated Sequences in Colorectal Cancer by Methylated CpG Island Amplification
Cancer Res., May 1, 1999; 59(10): 2307 - 2312.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.